Stockscreener 앱 받기
0.00
100.00%
-104.91
Exact Sciences Corp 주식(EXAS)의 최신 뉴스
Exact Sciences Corp stock (US30063P1057): Nasdaq-listed cancer diagnostics group steady after recent - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Abbott buyout clouds listing status and sector role - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Abbott deal reshapes outlook for cancer diagnostics leade - AD HOC NEWS
Canaccord Genuity Downgrades Exact Sciences (EXAS) - MSN
Exact Sciences stock (US30063P1057): Diagnostics peer update after Petrichor hiring - AD HOC NEWS
Exact Sciences stock (US30063P1057): screening business, oncology focus, and what U.S. investors are - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): diagnostics specialist in focus after leadership news - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): earnings backdrop and cancer diagnostics focus - AD HOC NEWS
Exact Sciences Corp stock (US30063P1057): acquisition plans stir debate around growth and dilution - AD HOC NEWS
Abbott Laboratories Stock (ABT) Moved Up by 3.04% on May 18: What Investors Need To Know - TradingKey
Exact Sciences stock (US30063P1057): latest business update and investor focus - AD HOC NEWS
TD Cowen Maintains Exact Sciences (EXAS) Buy Recommendation - MSN
Exact Sciences stock (US30063P1057): Screening leader faces a new investor test - AD HOC NEWS
Is Abbott’s Exact Sciences Deal And Nutrition Pivot Altering The Investment Case For Abbott (ABT)? - Yahoo Finance
Exact Sciences Corp. stock (US30063P1057): earnings beat and Abbott takeover reshape cancer diagnost - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Acquired by Abbott for $20.6B - AD HOC NEWS
Exact Sciences stock (US30063P1057): Q1 2026 revenue growth driven by Cologuard and Oncotype DX - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Risk channels signal institutional focus - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Q1 2026 earnings and screening advancements - AD HOC NEWS
BTIG Downgrades Exact Sciences (EXAS) - MSN
Exact Sciences Corp. stock (US30063P1057): Q4 earnings miss with revenue up 23% - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Q4 earnings miss with revenue growth - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Q4 2025 earnings miss on EPS despite revenue beat - AD HOC NEWS
Why the Stock Price of This Cancer Screening Company Soared 17% Thursday - MSN
Exact Sciences Corp. Stock (US30063P1057): Q1 2026 Earnings Release Scheduled for May 7 - AD HOC NEWS
Kevin Conroy (ABBOTT LABORATORIES: ABT) reports 131,451-share Form 3 holding - Stock Titan
Abbott Laboratories Stock (ABT) Opinions on Q1 Earnings and Exact Sciences Acquisition - Quiver Quantitative
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover - MSN
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits - MSN
Laura Friedman trades Exact Sciences for Abbott Laboratories in brokerage account - Investing.com India
Exact Sciences Corp. stock (US30063P1057): Is its cancer screening dominance strong enough to unlock - AD HOC NEWS
Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance - Investor's Business Daily
Abbott trims 2026 profit forecast on Exact deal hit, shares fall - Reuters
Q1 progress positions Abbott for accelerating growth in 2026 - Abbott
Abbott Cuts Profit Forecast After $21 Billion Deal, Shares Fall 4.6% - TradingView
Abbott cuts profit forecast in wake of Exact Sciences deal - Modern Healthcare
Abbott cuts 2026 profit forecast on Exact deal, shares fall - BioWorld News
Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag - Yahoo! Finance Canada
Earnings call transcript: Abbott Labs Q1 2026 results align with expectations - Investing.com
Abbott Laboratories Stock (ABT) Opened Down by 4.34% on Apr 16: What Investors Need To Know - TradingKey
Abbott reports Q1 earnings, completes Exact Sciences acquisition - Investing.com
Abbott lowers earnings forecast after $21B Exact Sciences buy - Yahoo Finance
Abbott results beat on medical device boost, Exact deal hits forecast - Yahoo Finance
Abbott (ABT) Q1 2026 earnings rise on adjusted basis after Exact Sciences acquisition - Stock Titan
Abbott adds Exact Sciences, expands into fast-growing cancer tests - Stock Titan
Abbott’s Exact acquisition drives med-tech M&A to $23.7B in March - BioWorld News
Abbott Verdict And Exact Sciences Deal Reshape Risk And Growth Outlook - Yahoo Finance
Exact Sciences to Participate in June Investor Conferences - Yahoo
Abbott’s $23 billion Exact Sciences deal revives diagnostics growth ambitions - S&P Global
Exact Sciences Corp. stock (US30063P1057): Why cancer screening leadership now drives investor focus - AD HOC NEWS
0.66%
1.47%
자본화:
|
볼륨(24시간):